Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial progenitor cells for vascular regeneration.

Takayuki Asahara1, Jeffrey M Isner

  • 1Cardiovascular Research and Medicine, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA. asa777@aol.com

Journal of Hematotherapy & Stem Cell Research
|May 2, 2002
PubMed
Summary

Endothelial progenitor cells (EPCs) from bone marrow aid neovascularization. These cells can be therapeutically harnessed for cardiovascular ischemic diseases, offering new treatment avenues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial and Functional Immune Profiling Identifies Impaired Vascular Repair in Human Myocardial Infarction.

Biomedicines·2026
Same author

First-in-human study to investigate the safety and efficacy of effective-mononuclear cell therapy for radiogenic xerostomia.

Regenerative therapy·2026
Same author

Efficacy of Repeated Administration of Cultured Human CD34<sup>+</sup> Cells Against Streptozotocin-Induced Diabetic Nephropathy in Rats.

Cells·2025
Same author

Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34<sup>+</sup> cell therapy: A clinical trial.

World journal of stem cells·2024
Same author

Cardioimmunology in Health and Diseases: Impairment of the Cardio-Spleno-Bone Marrow Axis Following Myocardial Infarction in Diabetes Mellitus.

International journal of molecular sciences·2024
Same author

Intravenous Regeneration-associated Cell Transplantation Enhances Tissue Recovery in Mice with Acute Ischemic Stroke.

The Keio journal of medicine·2024

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Cell Biology

Background:

  • Neovascularization involves both angiogenesis and postnatal vasculogenesis.
  • Bone marrow-derived endothelial progenitor cells (EPCs) circulate and respond to stimuli like ischemia.
  • EPCs can migrate to and integrate into sites requiring new blood vessel formation.

Purpose of the Study:

  • To review the therapeutic potential of endothelial progenitor cells (EPCs).
  • To explore EPCs as agents for treating cardiovascular ischemic diseases.

Main Methods:

  • Review of existing literature on EPCs and neovascularization.
  • Analysis of studies investigating EPCs in pathological and physiological conditions.

Main Results:

Related Experiment Videos

  • EPCs are present in circulation and can be mobilized.
  • EPCs demonstrate homing and incorporation capabilities at neovascularization sites.
  • Evidence supports EPCs' role in therapeutic angiogenesis.

Conclusions:

  • Endothelial progenitor cells hold significant therapeutic promise for cardiovascular ischemic diseases.
  • EPC-based therapies represent a potential strategy for regenerative cardiovascular medicine.